SIGIDA duo
Ophthalmology
Indications for use
- Exacerbation of seasonal or perennial allergic conjunctivitis;
- Inflammatory conditions related to irritation of the conjunctiva as a result of contact lens use, exposure to sunlight, cigarette smoke, contact with water in a swimming pool, etc.
Therapeutic class:
Co-formulated antisensitizer (Histamine 1 receptor antagonist + Alpha-adrenergic agonist)
INN
Naphazoline + diphenhydramine
OSD bottle
